Christopher L. Brummel

Author

Vertex Pharmaceuticals (United States)

Also Known As

C. Brummel, C. L. BRUMMEL, C. L. Brummel, C.L. Brummel, Christopher L Brummel, Christopher L. Brummel

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

Vertex Pharmaceuticals (United States)Pennsylvania State University Cornell University Earlham College

About

Christopher L. Brummel is an author at Vertex Pharmaceuticals (United States) specializing in chemistry, engineering, and natural sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Engineering	7	7	197
2	Natural Sciences	7	7	363
3	Applied Physics	5	5	158
4	Medicine	3	3	283
5	Allergy	1	1	87

Christopher L. Brummel

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
Atomic and Molecular Imaging at the Single-Cell Level with TOF-SIMS Thomas L. Colliver, Christopher L. Brummel, Michaeleen L. Pacholski, Analytical Chemistry	1997	258
A Mass Spectrometric Solution to the Address Problem of Combinatorial Libraries Christopher L. Brummel, Irene N. W. Lee, Ying Zhou, Science Combinatorial LibrariesPeptide EngineeringBiological Mass SpectrometryMolecular BiologyComputational Chemistry	1994	151
In Vitro and In Vivo Isotope Effects with Hepatitis C Protease Inhibitors: Enhanced Plasma Exposure of Deuterated Telaprevir versus Telaprevir in Rats François Maltais, Young Chun Jung, Minzhang Chen, Journal of Medicinal Chemistry	2009	97
Evaluation of Mass Spectrometric Methods Applicable to the Direct Analysis of Non-Peptide Bead-Bound Combinatorial Libraries Christopher L. Brummel, John C. Vickerman, Steven A. Carr, Analytical Chemistry	1996	88
Discovery of VX-509 (Decernotinib): A Potent and Selective Janus Kinase 3 Inhibitor for the Treatment of Autoimmune Diseases Luc J. Farmer, Mark W. Ledeboer, Thomas Hoock, Journal of Medicinal Chemistry ImmunologyImmunologic MechanismJanus Tyrosine KinasesCompound LibraryImmunotherapy	2015	87
Altering Metabolic Profiles of Drugs by Precision Deuteration 2: Discovery of a Deuterated Analog of Ivacaftor with Differentiated Pharmacokinetics for Clinical Development Scott L. Harbeson, Adam J. Morgan, Julie F. Liu, Journal of Pharmacology and Experimental Therapeutics	2017	73
Universal Lc–Ms Method For Minimized Carryover in A Discovery Bioanalytical Setting John S. Williams, Stephanie H Donahue, Hong Gao, Bioanalysis	2012	58
Biochemical Analysis of the Modular Enzyme Inosine 5′-Monophosphate Dehydrogenase Elmar Nimmesgern, James Black, Olga Futer, Protein Expression and Purification Cellular EnzymologyBiochemistryBiochemical Analysis	1999	58
High-resolution infrared spectroscopy of 2-fluoroethanol in a molecular beam Christopher L. Brummel, Steven W. Mork, Laura A. Philips The Journal of Chemical Physics Molecular SpectroscopyPhotochemistryVibrational Mode CouplingSpectroscopyNatural Sciences	1991	52
Evaluating LC–MS/MS To Measure Accumulation of Compounds within Bacteria Ramkumar Iyer, Zhengqi Ye, Annette Ferrari, ACS Infectious Diseases	2018	49

Page 1